This book is published in association with the Office of Health
Economics. This book is a vital, non-technical guide illuminating
recent developments within the five major European pharmaceutical
markets. It clearly explains pharmaceutical regulatory policies on
pricing and reimbursement, and their effects. Each chapter gives an
overview of the current market, including aims, effectiveness,
local markets, frameworks and politics, and then offers predictions
for the next decade. Pharmaceutical executives with interests in
marketing, market access and pricing will find this guide
invaluable, as will health economists, government advisors and
public affairs consultants. Public policy makers in areas such as
the Department of Health and The Treasury and senior health service
managers in hospitals will find it enlightening. It is also highly
relevant to policy shapers in academia and the media, and
undergraduate and postgraduate students of health economics, health
policy, pharmaceutical economics and healthcare management. "This
book aims not only to understand and discuss the mix of regulatory
measures introduced by national policy makers in order to achieve
their goals, but also to ascertain how these policies have actually
shaped and influenced the characteristics and functioning of
national pharmaceutical markets. In particular, each author has
provided an analysis of existing pricing and reimbursement
arrangements operating in their own country and an outline of
policy scenarios that might emerge in the next decade." - Martina
Garau and Jorge Mestre-Ferrandiz, in the Introduction.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
